Research Article

Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance

Table 6

Screening of prognosticators in EC patients with univariate and multivariate analysis.

CharacteristicsnHR (95% CI) univariate analysisP value univariate analysisHR (95% CI) multivariate analysisP value multivariate analysis

Age3441.066 (1.026–1.108)<0.0011.031 (0.984–1.080)0.201
CD47 (positive vs. negative)3440.438 (0.218–0.881)0.0210.754 (0.349–1.630)0.473
Cancer type (I vs. II)34410.275 (5.011–21.070)<0.0011.928 (0.629–5.907)0.251
Clinical stage (I and II vs. III and IV)3443.907 (2.714–5.625)<0.0012.410 (1.280–4.535)0.006
Histological grade (G3 vs. G1 and G2)3442.491 (1.756–3.532)<0.0010.861 (0.463–1.601)0.636
Infiltration depth (<1/2 vs. >1/2)3444.533 (2.250–9.131)<0.0010.432 (0.129–1.438)0.171
P53 (mutant vs. wild type)3440.777 (0.349–1.733)0.538
Ki67 (>50% vs. <50%)3442.244 (1.094–4.603)0.0281.218 (0.545–2.719)0.631
Lymph node metastasis (yes vs. no)34413.845 (6.872–27.894)<0.0014.675 (1.358–16.096)0.015